Introduction
Many patients are not aware of their olfactory deficits.[1] Therefore, olfactory testing is important. Additionally, common causes of olfactory decline create distinct patterns of olfactory deficits revealed through multicomponent olfactory tests.[2][3] Moreover, olfactory deficits may be a warning sign for neurodegenerative disorders or infections such as coronavirus disease 2019 (COVID-19).[4] Thus, olfactory testing may uncover important clues of potentially dangerous conditions.
Procedures
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Procedures
History and Ear Nose and Throat (ENT) Exam
Before performing the actual olfactory testing, taking a thorough history and performing a physical exam is important.[3] The history often suggests the diagnosis or helps to narrow down the differential diagnoses.[3] When taking the history, it is important to ask if there is an impairment with the sense of smell, an impairment with flavor/taste, or impairment of basic gustatory perception (such as salty, sweet, sour, or bitter)? Besides onset (such as sudden versus gradual) and course of the olfactory deficit (such as fluctuating or static), it is of central importance to also ask about quantitative olfactory dysfunction (such as the severity of olfactory alteration and the kind of odors affected) and qualitative olfactory dysfunction (distorted perception when the olfactory stimulus is present versus the perception of an odor when no odor stimulus is present). Furthermore, it is also important to inquire how olfactory decline impacts daily life (such as nutrition, interpersonal communication, and home safety). Finally, it is critical to obtain information about past medical history, head injuries, nasal symptoms (such as obstruction, rhinorrhea, and sneezing), past and current medication intake, allergies, smoking habits, toxin exposure, and relevant family history. Besides a general physical exam, a full ENT exam should be performed, an anterior rhinoscopy and a nasal endoscopy.
General Concept of Olfactory Testing
Olfactory impairment may be quantitative (= impairment of the strength) or qualitative (= impairment of the quality or degree of distortion). Olfactory testing primarily provides information about quantitative impairment, while history gives crucial information on qualitative impairment (such as distortion). The general concept of olfactory testing in the clinic is that an olfactory probe is presented at the patient’s nostrils, and the patient's response is documented. This is also referred to as psychophysical testing.[3][5] Olfactory testing requires a patient who can cooperate with the procedure, understand the instructions, and communicate the choices.[3] Olfactory tests are generally subdivided into odor threshold tests and suprathreshold tests of olfaction, such as for odor identification and discrimination. While tests for odor threshold are more likely to assess peripheral olfactory ability (such as a conductive and sensorineural function of the nose), suprathreshold tests are more likely to assess central processing of olfactory information (such as the functioning of central nervous system structures involved in olfaction).[2][3] Thus, olfactory testing may include both tests for odor threshold and suprathreshold tests of olfaction.
Odor Threshold Tests
For odor threshold tests, probes with either phenyl ethyl alcohol or n-butanol in increasing concentration are presented sequentially and typically intermixed with probes with no odor (“blanks”).[3][5] Patients are asked to answer, even if uncertain if they have perceived an odor (= forced-choice procedure).[3] When the transition between no detection and detection of the odor probe has been reached, the odor concentration slightly decreases and increases in several runs.[5] This is done to form the average of the reversals, increasing reliability.[5] Tests commonly used in clinical practice are the Snap & Sniff threshold test[6] and the threshold test using pen-like odor dispensing devices.[7]
Suprathreshold Tests of Olfaction
Suprathreshold tests use odor concentrations that are detectable by the patient. The most common suprathreshold tests used are odor identification tests such as the University of Pennsylvania Smell Identification Test (UPSIT) and the odor identification test with pen-like odor dispensing devices.[8][9] After written or visual answer options are presented to the patient, the patient sniffs an odor probe and is asked to choose an answer they think is right (= forced-choice procedure). The number of correct answers is recorded as the result of the test. Some odors presented are culturally specific and must be validated and reliable to the respective population assessed.[5] Normative data are available for most of these tests, which allow percentile ranking regarding sex and age.[3][5] A different suprathreshold test is the odor discrimination test with pen-like odor dispensing devices, such as the odor discrimination test.[9] In these tests, different odorous probes are presented to the patient, who is asked to memorize and distinguish different odors. Still, they do not have to name the odors presented specifically. Again, the number of correct answers is recorded as the test result. Suprathreshold odor tests are cognitively more challenging than odor threshold tests as they require executive functioning and semantic memory ability.[10] Another variant of suprathreshold tests for olfaction is a test for the hedonic value of an odor.[3][5] These tests assess how pleasant or unpleasant an odor is perceived and thus involve emotional components. Tests for hedonic value are rarely applied in clinical practice.
Tests to Screen for Gustatory Abilities
Patients often report impairment of taste when they have an impairment of smell.[3][5] This is because volatiles from food can reach the olfactory receptors through the nasal pharynx and stimulate the olfactory receptors on the olfactory epithelium through this retronasal route. The odors of food are perceived as “taste,” although the gustatory ability is normal. Therefore, olfactory testing should include screening for gustatory functioning, such as liquids applied to the tongue or the taste strip test.[11][12] Typically, the probe is dropped or placed on the patient's tongue, and the patient is asked to answer if it tastes salty, sour, better, or sweet. The number of correct answers is recorded as the result of the test.
Subjective Olfactory Self-assessment
We do not always become aware of olfactory signals (or their absence) and their impact on our behavior.[3][5] Additionally, a poor correlation exists between subjective patient self-assessment and more objective measures of olfactory abilities.[1][13] However, if subjective reporting of olfactory ability is needed, a scale from zero (none) to 10 (superb) may be used for epidemiological studies.[14]
Indications
Indications for olfactory testing include:
- Olfactory assessment is indicated when the patient reports on olfactory alterations.
- When the patient reports impairment of taste and flavor but an impairment of olfaction is suspected, olfactory testing, in addition to gustatory abilities, is indicated.
- Multicomponent olfactory testing may give additional information about the etiology of the olfactory decline.
- Olfactory assessment is indicated when an olfactory decline is suspected, but the patient does not perceive deficits with olfaction.
Potential Diagnosis
Olfactory Dysfunction Secondary to Sinonasal Disease
This is 1 of the most common causes of olfactory dysfunction and is often caused by rhinosinusitis (acute: < 12 weeks versus chronic ≥ 12 weeks) with hyposmia or anosmia as an important symptom besides rhinal symptoms (such as nasal discharge, pressure-like pain in the face and nasal obstruction).[15][16] The olfactory decline occurs gradually and is not associated with parosmia.[17] ENT exam may reveal nasal polyps and inflammation of the mucosa of the nose. Olfactory testing typically shows diminished odor threshold and discrimination but normal odor identification.[2] In addition to the olfactory testing, computer tomography of the skull base and paranasal sinuses may help document polys and other alterations of the sinuses, which are not visible with the clinical examination.
Post-infectious Olfactory Dysfunction
This is typically caused by (severe) upper respiratory tract infection by a virus, and it is 1 of the most common causes of olfactory decline. The onset of perceived loss of smell and possibly loss of flavor perception may occur suddenly. Patients often report parosmia (perception of an odor when an odor’s stimulus is present, but the perception is distorted). As with olfactory dysfunction secondary to sinonasal disease, olfactory testing with post-infectious olfactory dysfunction shows diminished odor threshold but normal odor identification.[2] How upper respiratory tract infections cause olfactory decline is incompletely understood. It is most likely related to an impairment of the olfactory epithelium and replacement with respiratory epithelium.[18][3] Most subjects with COVID-19 infection-related decline of the chemical senses fall into this category.[4]
Posttraumatic Olfactory Dysfunction
This may occur suddenly or with a delay after injury. Frequently, patients describe phantosmia (perception of an odor when no odorous stimulus is present). Typically, olfactory tests show diminished odor threshold and odor discrimination ability, while odor identification is normal.[2] To rule out any brain, skull base, or nasal injuries that may require surgery, imaging is essential in managing the patient.[19]
Olfactory Dysfunction Associated With Neurological Disease
Several neurological disorders are associated with olfactory decline; thus, a diminished sense of smell is not specific to a distinct neurological illness.[20] In neurological disorders, olfactory dysfunction is primarily characterized by diminished performance in suprathreshold tests, such as for odor identification and discrimination, while the odor threshold is normal. Also, the olfactory decline gradually begins, and there is no parosmia.[2] The 2 most common neurological diseases associated with olfactory decline are likely Alzheimer disease and idiopathic Parkinson disease.[21][22] Besides olfactory testing, information from patient history and the physical exam are important to support these diagnoses. For instance, patients with idiopathic Parkinson disease typically have a history of constipation, REM-Sleep behavior disorder, and depression in addition to olfactory decline many years before the onset of motor deficits such as rigidity, bradykinesia, tremor, stooped posture, and diminished arm swing when walking.[23] Brain imaging with the radioactive tracer Loflupane 123 is typically abnormal in subjects with idiopathic Parkinson disease, with some degree of asymmetry.[24] Patients with Alzheimer dementia change their personality (loss of interest); they can have difficulty keeping up with their daily routine and have cognitive decline, such as losing their train of thought and word-finding impairment.[25] Furthermore, depression, as 1 of the most common psychiatric disorders, can also cause diminished olfactory functioning and needs to be considered a differential diagnosis when clinically warranted.
Olfactory Dysfunction Associated with Exposure to Drugs and Toxins
Several drugs and toxins can cause olfactory decline.[26][27][3] Such medications mainly include anesthetics, antimicrobials, and antithyroid medications. Toxins that can cause a diminished sense of smell commonly include heavy metals, herbicides, solvents, and pesticides. Suspicion for this type of olfactory decline comes from patient history information, particularly work history and medications used.
Congenital Olfactory Dysfunction
This type of olfactory decline is present from birth and is severe. There is no parosmia. Besides olfactory testing, which typically reveals anosmia, information from neuroimaging is increasingly recognized as an important component in making the diagnosis.[3] For instance, magnetic resonance imaging in these patients commonly shows hypoplasia or aplasia of the olfactory bulb and shortening of the olfactory sulcus.[28][29] After making the diagnosis, patients should have a genetic and endocrine evaluation to assess the presence of diseases such as Kallmann syndrome and Turner syndrome, which commonly cause congenital olfactory dysfunction.[30][3][31]
Olfactory Dysfunction Associated with Aging
As with other sensory modalities, the sense of smell decreases with age. For instance, while about one-fifth of the general population has diminished olfaction,[32] about two-thirds of individuals aged 80 and older have olfactory decline.[33] Age-associated onset is gradual, and there is no parosmia. In olfactory testing with psychophysical tests, it is important to compare findings in a given patient with normative values to see if they are below the age- and sex-matched normal range. There are multiple causes for this olfactory decline, such as reduced mucociliary activity, diminished blood flow in the mucosa, and reduced mucus production in the nose.[34]
Other Disorders Associated With Olfactory Decline
Several different conditions can cause diminished olfaction. These may include:
- Tumors (of nose and brain)
- Surgery of the nose, sinuses, and skull (such as septoplasty or surgery of the anterior skull base)
- Disorders of the endocrine system and metabolic disorders (such as thyroid disorders and diabetes mellitus)
- Metabolic disorders such as diabetes mellitus
- Vitamin deficiency (such as deficiency of vitamin B12)
- Substance misuse (such as alcohol and cocaine)
- Nicotine use/tobacco use to some degree; however, this association is controversial.
Idiopathic olfactory dysfunction:
This diagnosis is made by carefully excluding all other causes of olfactory decline. Even though this diagnosis is the product of a comprehensive assessment, follow-up assessment with an interdisciplinary approach may be considered as the olfactory decline found could be an early sign of a neurodegenerative disorder such as Parkinson disease.[35]
Normal and Critical Findings
Quantitative Olfactory Function and Dysfunction
Normosmia: olfactory function is normally compared to age- and sex-matched normative olfactory test values.
Hyposmia: The score on olfactory tests is lower than the normal range, but the olfactory ability present is useful for the patient in daily life (such as the ability to detect the fumes of fire and the odor of natural gas).
Hyperosmia: olfactory ability falls abnormally above the normal range.
Anosmia: no olfactory functioning is present.
Functional Anosmia: The score on olfactory tests falls markedly below the normal range, but the patient's olfactory function is not useful in daily life.
Qualitative Olfactory Function and Dysfunction
Parosmia: the perception of an odor when an odor’s stimulus is present, but the perception is distorted (for instance, the odor of a rose is perceived as the sulfurous odor of a rotten egg).
Phantosmia: the perception of an odor when no odorous stimulus is present (for instance, the perception of a flower fragrance but no odor stimulus such as a flower is present).
Cacosmia: when the perception of an unpleasant odor without the presence of an odor stimulus.
Interfering Factors
Suprathreshold olfactory tests, such as those for odor identification and discrimination, require semantic and episodic memory.[10][36] Therefore, cognitive deficits in these domains interfere with suprathreshold olfactory testing. In contrast, odor threshold tests appear to be unrelated to cognitive factors.[10] Besides cognitive deficits, psychiatric illnesses such as depression and anxiety may impact the sense of smell.[37][38] Thus, in case of clinical suspicion for cognitive deficits and psychiatric illnesses, respective referrals should be considered.
Complications
There are no known complications of olfactory testing. However, the olfactory testing procedure may be tiring for patients as complete olfactory testing can take up to 30 minutes. Following international guidelines, anterior rhinoscopy and nasal endoscopy should be done as part of the ENT evaluation to rule out intranasal pathology, potentially impeding the sense of smell.[3] The complications of these procedures have been reviewed before.[39]
Patient Safety and Education
The patient is instructed that the olfactory tests measure the lowest concentration of an odor the patient can detect and how well the patient can identify and differentiate odors. Furthermore, the patient has informed the tests most likely help identify the cause of the patient’s olfactory disturbance, which in turn can lead to a specific treatment. Moreover, the patient is educated that with some olfactory tests, an odor may not be consciously perceptible, but they are always asked to answer, even if it is a guess.
Clinical Significance
For several reasons, olfactory testing is of clinical significance.[3][5] First, olfactory testing gives a more objective measure of olfactory abilities. This is important as many patients are not aware of the degree of their olfactory deficits. Second, many patients experience an olfactory decline as a diminished perception of flavor. Therefore, olfactory testing can explore if a patient is experiencing olfactory rather than gustatory decline. Third, olfactory testing with multicomponent tests, including olfactory threshold testing and suprathreshold tests such as odor identification and odor discrimination, can reveal a pattern of olfactory decline, which may help to delineate the etiology of the olfactory decline.[2] For instance, a disease that primarily affects the nose, such as sinonasal disease, negatively impacts odor threshold while suprathreshold test results are normal.
In contrast, diseases of the brain that affect olfaction, such as Parkinson disease, negatively impact performance on suprathreshold tests while the odor threshold is normal. Thus, besides history and a physical exam, olfactory testing can be fundamental in making a diagnosis, leading to proper treatment. Finally, olfactory testing is easy to do.[40] Healthcare providers can learn the correct administration of olfactory testing in little time. The instructions to the patients are straightforward, and olfactory testing in the clinic is inexpensive and time-efficient.
References
Adams DR, Wroblewski KE, Kern DW, Kozloski MJ, Dale W, McClintock MK, Pinto JM. Factors Associated with Inaccurate Self-Reporting of Olfactory Dysfunction in Older US Adults. Chemical senses. 2017 Mar 1:42(3):223-231. doi: 10.1093/chemse/bjw108. Epub [PubMed PMID: 28007787]
Whitcroft KL, Cuevas M, Haehner A, Hummel T. Patterns of olfactory impairment reflect underlying disease etiology. The Laryngoscope. 2017 Feb:127(2):291-295. doi: 10.1002/lary.26229. Epub 2016 Aug 24 [PubMed PMID: 27556251]
Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, Damm M, Frasnelli J, Gudziol H, Gupta N, Haehner A, Holbrook E, Hong SC, Hornung D, Hüttenbrink KB, Kamel R, Kobayashi M, Konstantinidis I, Landis BN, Leopold DA, Macchi A, Miwa T, Moesges R, Mullol J, Mueller CA, Ottaviano G, Passali GC, Philpott C, Pinto JM, Ramakrishnan VJ, Rombaux P, Roth Y, Schlosser RA, Shu B, Soler G, Stjärne P, Stuck BA, Vodicka J, Welge-Luessen A. Position paper on olfactory dysfunction. Rhinology. 2016 Jan 31:56(1):1-30. doi: 10.4193/Rhino16.248. Epub [PubMed PMID: 28623665]
Whitcroft KL,Hummel T, Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA. 2020 Jun 23 [PubMed PMID: 32432682]
Doty RL. Psychophysical testing of smell and taste function. Handbook of clinical neurology. 2019:164():229-246. doi: 10.1016/B978-0-444-63855-7.00015-0. Epub [PubMed PMID: 31604550]
Doty RL, Wylie C, Potter M, Beston R, Cope B, Majam K. Clinical validation of the olfactory detection threshold module of the Snap & Sniff® olfactory test system. International forum of allergy & rhinology. 2019 Sep:9(9):986-992. doi: 10.1002/alr.22377. Epub 2019 Jul 8 [PubMed PMID: 31283113]
Level 1 (high-level) evidenceHummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chemical senses. 1997 Feb:22(1):39-52 [PubMed PMID: 9056084]
Doty RL,Shaman P,Dann M, Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiology [PubMed PMID: 6463130]
Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf S. "Sniffin' sticks": screening of olfactory performance. Rhinology. 1996 Dec:34(4):222-6 [PubMed PMID: 9050101]
Hedner M, Larsson M, Arnold N, Zucco GM, Hummel T. Cognitive factors in odor detection, odor discrimination, and odor identification tasks. Journal of clinical and experimental neuropsychology. 2010 Dec:32(10):1062-7. doi: 10.1080/13803391003683070. Epub 2010 Apr 30 [PubMed PMID: 20437286]
Hummel T, Landis BN, Hüttenbrink KB. Smell and taste disorders. GMS current topics in otorhinolaryngology, head and neck surgery. 2011:10():Doc04. doi: 10.3205/cto000077. Epub 2012 Apr 26 [PubMed PMID: 22558054]
Mueller C,Kallert S,Renner B,Stiassny K,Temmel AF,Hummel T,Kobal G, Quantitative assessment of gustatory function in a clinical context using impregnated [PubMed PMID: 12677732]
Level 1 (high-level) evidenceNordin S, Monsch AU, Murphy C. Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between self-reported and diagnosed smell sensitivity. The journals of gerontology. Series B, Psychological sciences and social sciences. 1995 Jul:50(4):P187-92 [PubMed PMID: 7606530]
Level 2 (mid-level) evidenceHoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Annals of the New York Academy of Sciences. 1998 Nov 30:855():716-22 [PubMed PMID: 9929676]
Level 1 (high-level) evidenceFokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, Georgalas C, Goossens H, Harvey R, Hellings P, Hopkins C, Jones N, Joos G, Kalogjera L, Kern B, Kowalski M, Price D, Riechelmann H, Schlosser R, Senior B, Thomas M, Toskala E, Voegels R, Wang de Y, Wormald PJ. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology. Supplement. 2012 Mar:23():3 p preceding table of contents, 1-298 [PubMed PMID: 22764607]
Rosenfeld RM,Piccirillo JF,Chandrasekhar SS,Brook I,Ashok Kumar K,Kramper M,Orlandi RR,Palmer JN,Patel ZM,Peters A,Walsh SA,Corrigan MD, Clinical practice guideline (update): adult sinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2015 Apr; [PubMed PMID: 25832968]
Level 1 (high-level) evidenceEnriquez K, Lehrer E, Mullol J. The optimal evaluation and management of patients with a gradual onset of olfactory loss. Current opinion in otolaryngology & head and neck surgery. 2014 Feb:22(1):34-41. doi: 10.1097/MOO.0000000000000013. Epub [PubMed PMID: 24370953]
Level 3 (low-level) evidenceJafek BW, Murrow B, Michaels R, Restrepo D, Linschoten M. Biopsies of human olfactory epithelium. Chemical senses. 2002 Sep:27(7):623-8 [PubMed PMID: 12200342]
Howell J, Costanzo RM, Reiter ER. Head trauma and olfactory function. World journal of otorhinolaryngology - head and neck surgery. 2018 Mar:4(1):39-45. doi: 10.1016/j.wjorl.2018.02.001. Epub 2018 Mar 14 [PubMed PMID: 30035260]
Demarquay G, Ryvlin P, Royet JP. [Olfaction and neurological diseases: a review of the literature]. Revue neurologique. 2007 Feb:163(2):155-67 [PubMed PMID: 17351535]
Level 3 (low-level) evidenceAttems J, Walker L, Jellinger KA. Olfactory bulb involvement in neurodegenerative diseases. Acta neuropathologica. 2014 Apr:127(4):459-75. doi: 10.1007/s00401-014-1261-7. Epub 2014 Feb 20 [PubMed PMID: 24554308]
Doty RL. Olfaction in Parkinson's disease and related disorders. Neurobiology of disease. 2012 Jun:46(3):527-52. doi: 10.1016/j.nbd.2011.10.026. Epub 2011 Dec 20 [PubMed PMID: 22192366]
Level 3 (low-level) evidenceHaehner A, Hummel T, Reichmann H. A clinical approach towards smell loss in Parkinson's disease. Journal of Parkinson's disease. 2014:4(2):189-95. doi: 10.3233/JPD-130278. Epub [PubMed PMID: 24322062]
Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Movement disorders : official journal of the Movement Disorder Society. 2004 Oct:19(10):1196-202 [PubMed PMID: 15390014]
Velayudhan L, Gasper A, Pritchard M, Baillon S, Messer C, Proitsi P. Pattern of Smell Identification Impairment in Alzheimer's Disease. Journal of Alzheimer's disease : JAD. 2015:46(2):381-7. doi: 10.3233/JAD-142838. Epub [PubMed PMID: 25757648]
Doty RL, Philip S, Reddy K, Kerr KL. Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. Journal of hypertension. 2003 Oct:21(10):1805-13 [PubMed PMID: 14508182]
Ackerman DL, Unützer J, Greenland S, Gitlin M. Inpatient treatment of depression and associated hospital charges. Pharmacoepidemiology and drug safety. 2002 Apr-May:11(3):219-27 [PubMed PMID: 12051121]
Abolmaali ND, Hietschold V, Vogl TJ, Hüttenbrink KB, Hummel T. MR evaluation in patients with isolated anosmia since birth or early childhood. AJNR. American journal of neuroradiology. 2002 Jan:23(1):157-64 [PubMed PMID: 11827889]
Huart C, Meusel T, Gerber J, Duprez T, Rombaux P, Hummel T. The depth of the olfactory sulcus is an indicator of congenital anosmia. AJNR. American journal of neuroradiology. 2011 Nov-Dec:32(10):1911-4. doi: 10.3174/ajnr.A2632. Epub 2011 Aug 25 [PubMed PMID: 21868619]
Ros C, Alobid I, Centellas S, Balasch J, Mullol J, Castelo-Branco C. Loss of smell but not taste in adult women with Turner's syndrome and other congenital hypogonadisms. Maturitas. 2012 Nov:73(3):244-50. doi: 10.1016/j.maturitas.2012.07.012. Epub 2012 Aug 11 [PubMed PMID: 22889822]
Level 2 (mid-level) evidenceKim SH. Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future. Endocrinology and metabolism (Seoul, Korea). 2015 Dec:30(4):456-66. doi: 10.3803/EnM.2015.30.4.456. Epub [PubMed PMID: 26790381]
Vennemann MM,Hummel T,Berger K, The association between smoking and smell and taste impairment in the general population. Journal of neurology. 2008 Aug; [PubMed PMID: 18677645]
Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002 Nov 13:288(18):2307-12 [PubMed PMID: 12425708]
Attems J, Walker L, Jellinger KA. Olfaction and Aging: A Mini-Review. Gerontology. 2015:61(6):485-90. doi: 10.1159/000381619. Epub 2015 May 9 [PubMed PMID: 25968962]
Haehner A, Masala C, Walter S, Reichmann H, Hummel T. Incidence of Parkinson's disease in a large patient cohort with idiopathic smell and taste loss. Journal of neurology. 2019 Feb:266(2):339-345. doi: 10.1007/s00415-018-9135-x. Epub 2018 Nov 28 [PubMed PMID: 30488238]
Westervelt HJ, Ruffolo JS, Tremont G. Assessing olfaction in the neuropsychological exam: the relationship between odor identification and cognition in older adults. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. 2005 Aug:20(6):761-9 [PubMed PMID: 15951153]
Croy I,Hummel T, Olfaction as a marker for depression. Journal of neurology. 2017 Apr; [PubMed PMID: 27393116]
Kamath V, Paksarian D, Cui L, Moberg PJ, Turetsky BI, Merikangas KR. Olfactory processing in bipolar disorder, major depression, and anxiety. Bipolar disorders. 2018 Sep:20(6):547-555. doi: 10.1111/bdi.12625. Epub 2018 Feb 13 [PubMed PMID: 29441710]
Noone KE. Rhinoscopy, pharyngoscopy, and laryngoscopy. The Veterinary clinics of North America. Small animal practice. 2001 Jul:31(4):671-89 [PubMed PMID: 11487950]
Level 3 (low-level) evidenceRombaux P, Collet S, Martinage S, Eloy P, Bertrand B, Negoias S, Hummel T. Olfactory testing in clinical practice. B-ENT. 2009:5 Suppl 13():39-51 [PubMed PMID: 20084804]